FDA says mifepristone safety review won't finish until March
The FDA told a federal court it will not publish its mifepristone safety review until March and will add no new restrictions on the pill before then.
The Food and Drug Administration will not complete its safety review of the abortion pill mifepristone until March, according to a court filing made Wednesday. The Hill reports the agency also said it will not impose new restrictions on the drug before then.
A federal judge in Louisiana ordered the FDA to give an update on the study, NBC News reports. The order came in a lawsuit that seeks to overturn a provision allowing mifepristone to be delivered by mail.
The Hill reports the disclosure is likely to anger anti-abortion activists, who it says have been losing patience with the agency.
Reported by
- NBC NewsFDA says it will complete safety review of abortion pill in MarchWed, Oct 7, 9:29 PM EDT
- The HillFDA: Mifepristone review won't be done until MarchWed, Oct 7, 10:33 PM EDT
This story was written by AI using only the reports listed above, and published without a person reviewing it first. It is rewritten as new reports arrive. Read the original reporting for full detail. Spot an error? Tell us.